An observational study in Infertility, Female and Fertility Disorders, sponsored by Clinica de la Mujer Medicina Reproductiva, Chile. Completed. Open to female participants aged 21 Years to 30 Years. Per ClinicalTrials.gov, last updated 2022-10-13.
Sponsored by Clinica de la Mujer Medicina Reproductiva, Chile · Observational
Prospective controlled study to assess the reproductive outcomes of OD recipients in which the donors were subjected to the DYG protocol (20mg/day) compared with those subjected to the short protocol with cetrorelix (0.25 mg/day) from Day 7 or since a leading follicle reached 14 mm. The OD cycles were triggered with triptoreline acetate and the trigger criterion was ≥3 follicles of diameter >18mm.
Oocyte donors undergoing controlled ovarian stimulation
Exclusion Criteria:
oocyte donors undergoing controlled ovarian stimulation in a progestin-primed ovarian stimulation protocol with DYG protocol (20mg/day)
Drug: Dydrogesterone
oocyte donors undergoing controlled ovarian stimulation in a GnRH antagonist protocol with cetrorelix (0.25 mg/day) from Day 7 or since a leading follicle reached 14 mm
progestin primed ovarian stimulation
Live Birth Rate per transfer
Time frame: 40 weeks after ET
Clinical pregnancy per transfer
Time frame: 12 weeks after ET
Miscarriage rate
Time frame: 12 weeks after ET
Number of oocytes retrieved
Time frame: at time of oocyte retrieval
Number of mature oocytes
Time frame: 1 day after IVF
Number of fertilized oocytes
Time frame: 1 day after IVF
Number of blastocists
Time frame: 5-6 days after OPU
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Clinica de la Mujer Medicina Reproductiva, Chile